These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36638558)

  • 1. Describing model relations: The case of the capital asset pricing model (CAPM) family in financial economics.
    Vergara-Fernández M; Heilmann C; Szymanowska M
    Stud Hist Philos Sci; 2023 Feb; 97():91-100. PubMed ID: 36638558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An augmented capital asset pricing model using new macroeconomic determinants.
    Pham CD; Phuoc LT
    Heliyon; 2020 Oct; 6(10):e05185. PubMed ID: 33102838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is estimating the Capital Asset Pricing Model using monthly and short-horizon data a good choice?
    Pham CD; Phuoc LT
    Heliyon; 2020 Jul; 6(7):e04339. PubMed ID: 32743085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The systematic risk estimation models: A different perspective.
    Phuoc LT; Pham CD
    Heliyon; 2020 Feb; 6(2):e03371. PubMed ID: 32072058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contextualist model evaluation: models in financial economics and index funds.
    Vergara-Fernández M; Heilmann C; Szymanowska M
    Eur J Philos Sci; 2023; 13(1):6. PubMed ID: 36714209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entropy-based financial asset pricing: Evidence from Pakistan.
    Wang S; Khan SA; Munir M; Alhajj R; Khan YA
    PLoS One; 2022; 17(12):e0278236. PubMed ID: 36548250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of capital to the hospital sector.
    Sloan FA; Valvona J; Hassan M; Morrisey MA
    J Health Econ; 1988 Mar; 7(1):25-45. PubMed ID: 10302653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced capital-asset pricing model for the reconstruction of bipartite financial networks.
    Squartini T; Almog A; Caldarelli G; van Lelyveld I; Garlaschelli D; Cimini G
    Phys Rev E; 2017 Sep; 96(3-1):032315. PubMed ID: 29347051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug development costs when financial risk is measured using the Fama-French three-factor model.
    Vernon JA; Golec JH; Dimasi JA
    Health Econ; 2010 Aug; 19(8):1002-5. PubMed ID: 19655335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative Entropy and Minimum-Variance Pricing Kernel in Asset Pricing Model Evaluation.
    Rojo-Suárez J; Alonso-Conde AB
    Entropy (Basel); 2020 Jun; 22(7):. PubMed ID: 33286493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entropy-based financial asset pricing.
    Ormos M; Zibriczky D
    PLoS One; 2014; 9(12):e115742. PubMed ID: 25545668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's your real cost of capital?
    McNulty JJ; Yeh TD; Schulze WS; Lubatkin MH
    Harv Bus Rev; 2002 Oct; 80(10):114-21, 130. PubMed ID: 12389465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Empirical Study on the Influence of the Basic Medical Insurance for Urban and Rural Residents on Family Financial Asset Allocation.
    Li S; Yang Y
    Front Public Health; 2021; 9():725608. PubMed ID: 34458230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pricing medicines: theory and practice, challenges and opportunities.
    Gregson N; Sparrowhawk K; Mauskopf J; Paul J
    Nat Rev Drug Discov; 2005 Feb; 4(2):121-30. PubMed ID: 15688076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risky business--health care finance and the VA.
    Bromley HR
    Physician Exec; 2008; 34(3):42-4, 46-7. PubMed ID: 18605271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sustainability of stock price fluctuations: Explanation from a recursive dynamic model.
    Xie J; Xia W; Gao B
    PLoS One; 2021; 16(8):e0255081. PubMed ID: 34403423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's the controversy behind capital payment under prospective pricing?
    Warner G
    Trustee; 1984 Sep; 37(9):39-40. PubMed ID: 10273576
    [No Abstract]   [Full Text] [Related]  

  • 18. Valuation of Medical Innovation Handling with Uncertainty and Risk.
    Nuijten M; Capri S
    J Mark Access Health Policy; 2024 Sep; 12(3):199-208. PubMed ID: 39193543
    [No Abstract]   [Full Text] [Related]  

  • 19. The capital-asset-pricing model and arbitrage pricing theory: a unification.
    Ali Khan M; Sun Y
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4229-32. PubMed ID: 11038614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dynamic factor model of the evaluation of the financial crisis in Turkey.
    Sezgin F; Kinay B
    Bull Soc Sci Med Grand Duche Luxemb; 2010; Spec No 1(1):109-17. PubMed ID: 20653182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.